Back
MicroSectors FANG+ Index -3X Inverse Leveraged ETN Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison
Sell
46
FNGD
MicroSectors FANG+ Index -3X Inverse Leveraged ETN
Last Price:
$5.24
Seasonality Move:
-11.48%
Sell
34
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$53.24
Seasonality Move:
-11.9%
Sell
46
MicroSectors FANG+ Index -3X Inverse Leveraged ETN (FNGD)
is a Sell
Is MicroSectors FANG+ Index -3X Inverse Leveraged ETN a Buy, Sell or Hold?
-
The current MicroSectors FANG+ Index -3X Inverse Leveraged ETN [FNGD] share price is $5.35. The Score for FNGD is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
FNGD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FNGD Stock Price Chart
What is MicroSectors FANG+ Index -3X Inverse Leveraged ETN's stock price today?
-
The MicroSectors FANG+ Index -3X Inverse Leveraged ETN share price today is $5.35The current trend is moderately bullish and FNGD is experiencing slight buying pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals, Inc.'s stock price today?
-
The Crinetics Pharmaceuticals, Inc. share price today is $53.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.
FNGD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 58.15 | Buy |
| Chaikin Money Flow: | 19014205 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.66 - 5.32) | Buy |
| Bollinger Bands (100): | (4.61 - 5.59) | Buy |
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.28 | Buy |
| Relative Strength Index (14 RSI): | 65.68 | Buy |
| Chaikin Money Flow: | -209678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.25 - 50.15) | Buy |
| Bollinger Bands (100): | (35.32 - 47.44) | Buy |
FNGD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.22 | Buy |
| 20-day SMA: | 5.09 | Buy |
| 50-day SMA: | 4.84 | Buy |
| 200-day SMA: | 7.54 | Sell |
| 8-day EMA: | 5.25 | Buy |
| 20-day EMA: | 5.12 | Buy |
| 50-day EMA: | 5.04 | Buy |
| 200-day EMA: | 8.65 | Sell |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.77 | Buy |
| 20-day SMA: | 48.57 | Buy |
| 50-day SMA: | 45.67 | Buy |
| 200-day SMA: | 36.1 | Buy |
| 8-day EMA: | 49.69 | Buy |
| 20-day EMA: | 48.35 | Buy |
| 50-day EMA: | 45.87 | Buy |
| 200-day EMA: | 40.28 | Buy |
MicroSectors FANG+ Index -3X Inverse Leveraged ETN Earnings Growth & FNGD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.
MicroSectors FANG+ Index -3X Inverse Leveraged ETN Technical Analysis
| Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Crinetics Pharmaceuticals, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||